Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer

Author： Fagnoni Philippe   Limat Samuel   Chaigneau Loïc   Guardiola Emmanuel   Briaud Stéphanie   Schmitt Bernard   Merrouche Yacine   Pivot Xavier   Woronoff-Lemsi Marie-Christine  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.14, Iss.10, 2006-10, pp. : 1030-1037

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of adjuvant chemotherapy delay on survival in cancer breast patients

By Ghany Dalia  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 1, 2013-01 ,pp. : 20-24

Springer Publishing Company

Access to resources Recommend Favorite

Quality of life after adjuvant chemotherapy for breast cancer

By Broeckel J.A.   Jacobsen P.B.   Balducci L.   Horton J.   Lyman G.H.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 141-150

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy for breast cancer in patients with schizophrenia

By            

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 845-850

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant chemotherapy in young women with breast cancer

By Rodríguez-Lescure Álvaro  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-09 ,pp. : 39-41

Springer Publishing Company

Access to resources Recommend Favorite

Early breast cancer: Adjuvant chemotherapy or radiotherapy, or both?

By Arriagada Rodrigo  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 514-516

Informa Healthcare

Access to resources Recommend Favorite